Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2009

Nov 3, 2009

29831_dirs_2009-11-03_95efb6ef-76e1-46f0-b33d-24ed423af131.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-10-30

Reporting Person: MCLEOD MARY S (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-10-30 Common Stock A 8808 Acquired 109307 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-10-30 Stock Appreciation Rights $17.03 A 32751 Acquired 2014-10-30 Common Stock (32751) Direct

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date.

F2: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.